국소 흉터 치료 시장 규모, 점유율 및 동향 분석 보고서, 최종 용도별, 흉터 유형별, 제품별, 지역별 전망 및 예측(2023-2030년)

The Global Topical Scar Treatment Market size is expected to reach $28.9 billion by 2030, rising at a market growth of 9.3% CAGR during the forecast period.

Consumers in North America are often well-informed about skincare trends and are likely to seek solutions for scar reduction. Therefore, the North America region captured $5,287.0 million revenue in the market in 2022. Individuals in North America can browse and buy various skincare products, including topical scar treatments, through online retail.

Social media platforms, including Instagram, TikTok, and YouTube, provide a global stage for beauty trends and skincare routines. Influencers and beauty enthusiasts often share their skincare journeys, including scar management experiences and increasing visibility and awareness of topical scar treatments. Therefore, the market is expanding significantly due to the influence of social media and beauty trends.

Additionally, seniors often undergo surgical procedures for various health conditions, ranging from joint replacements to cardiac surgeries. Post-surgical scarring is common, creating a demand for scar management solutions, including topical treatments. Thus, because of the increasing number of senior citizens, the market is anticipated to increase significantly.

However, Individuals with lower disposable incomes may struggle to afford high-cost advanced formulations. This can reduce accessibility to effective scar treatments for population segments, impacting market penetration. Consumers are often sensitive to product prices, and high-cost formulations may discourage potential buyers. Thus, high cost can slow down the growth of the market.

The skincare industry, like many others, experienced disruptions in the supply chain due to lockdowns, restrictions on movement, and closure of manufacturing facilities. This impacted the availability of raw materials and the production of scar treatment products. Economic uncertainties and changes in consumer spending patterns affected consumers' purchasing power, potentially impacting the sales of premium skincare products, including specialized scar treatments. Thus, the COVID-19 pandemic had a moderate effect on the market.

By End-use Analysis

On the basis of end-use, the market is divided into hospitals, clinics, and homecare. In 2022, the hospitals segment dominated the market with 42.6% revenue share. Hospitals frequently use topical scar treatments to manage and minimize scarring resulting from surgical procedures. Scar prevention and reduction are essential aspects of post-operative care.

By Scar Type Analysis

Based on scar type, the market is classified into atrophic scars, hypertrophic & keloid scars, contracture scars, and stretch marks. The hypertrophic & keloid scars segment acquired 26.5% revenue share in the market in 2022. Hypertrophic & keloid scars are often associated with itching and discomfort.

By Product Analysis

By product, the market is categorized into creams, gels, silicon sheets, and others. In 2022, the creams segment held 38.1% revenue share in the market. Creams are user-friendly and easy to apply, making them convenient for individuals seeking a hassle-free scar treatment option. This ease of application encourages regular use, which is crucial for the effectiveness of scar treatments.

By Regional Analysis

Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the Asia Pacific region acquired 27.1% revenue share in the market. Rising disposable income in certain countries within the Asia Pacific region allows consumers to spend more on skincare and cosmetic products, including topical scar treatments.

List of Key Companies Profiled

• Smith & Nephew PLC
• Lumenis Be Ltd.
• Merz Pharma GmbH & Co. KGaA
• Sonoma Pharmaceuticals Inc.
• Molnlycke Health Care AB
• Suneva Medical, Inc.
• Perrigo Company PLC
• Cynosure, LLC
• Newmedical Technology Inc.
• Integra LifeSciences Holdings Corporation

Global Topical Scar Treatment Market Report Segmentation

By End-use

• Hospitals
• Clinics
• Homecare

By Scar Type

• Atrophic Scars
• Hypertrophic & Keloid Scars
• Contracture Scars
• Stretch Marks

By Product

• Creams
• Gels
• Silicon Sheets
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1.Market Scope & Methodology

• 1.1Market Definition
• 1.2Objectives
• 1.3Market Scope
• 1.4Segmentation
  • 1.4.1Global Topical Scar Treatment Market, by End-use
  • 1.4.2Global Topical Scar Treatment Market, by Scar Type
  • 1.4.3Global Topical Scar Treatment Market, by Product
  • 1.4.4Global Topical Scar Treatment Market, by Geography
• 1.5Methodology for the research

Chapter 2.Market at a Glance

• 2.1Key Highlights

Chapter 3.Market Overview

• 3.1Introduction
  • 3.1.1Overview
    • 3.1.1.1Market Composition and Scenario
• 3.2Key Factors Impacting the Market
  • 3.2.1Market Drivers
  • 3.2.2Market Opportunities
  • 3.2.3Market Restraints
  • 3.2.4Market Challenges
• 3.3Porter's Five Forces Analysis

Chapter 4.Global Topical Scar Treatment Market by End-use

• 4.1Global Hospitals Market by Region
• 4.2Global Clinics Market by Region
• 4.3Global Homecare Market by Region

Chapter 5.Global Topical Scar Treatment Market by Scar Type

• 5.1Global Atrophic Scars Market by Region
• 5.2Global Hypertrophic & Keloid Scars Market by Region
• 5.3Global Contracture Scars Market by Region
• 5.4Global Stretch Marks Market by Region

Chapter 6.Global Topical Scar Treatment Market by Product

• 6.1Global Creams Market by Region
• 6.2Global Gels Market by Region
• 6.3Global Silicon Sheets Market by Region
• 6.4Global Others Market by Region

Chapter 7.Global Topical Scar Treatment Market by Region

• 7.1North America Topical Scar Treatment Market
  • 7.1.1North America Topical Scar Treatment Market by End-use
    • 7.1.1.1North America Hospitals Market by Country
    • 7.1.1.2North America Clinics Market by Country
    • 7.1.1.3North America Homecare Market by Country
  • 7.1.2North America Topical Scar Treatment Market by Scar Type
    • 7.1.2.1North America Atrophic Scars Market by Country
    • 7.1.2.2North America Hypertrophic & Keloid Scars Market by Country
    • 7.1.2.3North America Contracture Scars Market by Country
    • 7.1.2.4North America Stretch Marks Market by Country
  • 7.1.3North America Topical Scar Treatment Market by Product
    • 7.1.3.1North America Creams Market by Country
    • 7.1.3.2North America Gels Market by Country
    • 7.1.3.3North America Silicon Sheets Market by Country
    • 7.1.3.4North America Others Market by Country
  • 7.1.4North America Topical Scar Treatment Market by Country
    • 7.1.4.1US Topical Scar Treatment Market
      • 7.1.4.1.1US Topical Scar Treatment Market by End-use
      • 7.1.4.1.2US Topical Scar Treatment Market by Scar Type
      • 7.1.4.1.3US Topical Scar Treatment Market by Product
    • 7.1.4.2Canada Topical Scar Treatment Market
      • 7.1.4.2.1Canada Topical Scar Treatment Market by End-use
      • 7.1.4.2.2Canada Topical Scar Treatment Market by Scar Type
      • 7.1.4.2.3Canada Topical Scar Treatment Market by Product
    • 7.1.4.3Mexico Topical Scar Treatment Market
      • 7.1.4.3.1Mexico Topical Scar Treatment Market by End-use
      • 7.1.4.3.2Mexico Topical Scar Treatment Market by Scar Type
      • 7.1.4.3.3Mexico Topical Scar Treatment Market by Product
    • 7.1.4.4Rest of North America Topical Scar Treatment Market
      • 7.1.4.4.1Rest of North America Topical Scar Treatment Market by End-use
      • 7.1.4.4.2Rest of North America Topical Scar Treatment Market by Scar Type
      • 7.1.4.4.3Rest of North America Topical Scar Treatment Market by Product
• 7.2Europe Topical Scar Treatment Market
  • 7.2.1Europe Topical Scar Treatment Market by End-use
    • 7.2.1.1Europe Hospitals Market by Country
    • 7.2.1.2Europe Clinics Market by Country
    • 7.2.1.3Europe Homecare Market by Country
  • 7.2.2Europe Topical Scar Treatment Market by Scar Type
    • 7.2.2.1Europe Atrophic Scars Market by Country
    • 7.2.2.2Europe Hypertrophic & Keloid Scars Market by Country
    • 7.2.2.3Europe Contracture Scars Market by Country
    • 7.2.2.4Europe Stretch Marks Market by Country
  • 7.2.3Europe Topical Scar Treatment Market by Product
    • 7.2.3.1Europe Creams Market by Country
    • 7.2.3.2Europe Gels Market by Country
    • 7.2.3.3Europe Silicon Sheets Market by Country
    • 7.2.3.4Europe Others Market by Country
  • 7.2.4Europe Topical Scar Treatment Market by Country
    • 7.2.4.1Germany Topical Scar Treatment Market
      • 7.2.4.1.1Germany Topical Scar Treatment Market by End-use
      • 7.2.4.1.2Germany Topical Scar Treatment Market by Scar Type
      • 7.2.4.1.3Germany Topical Scar Treatment Market by Product
    • 7.2.4.2UK Topical Scar Treatment Market
      • 7.2.4.2.1UK Topical Scar Treatment Market by End-use
      • 7.2.4.2.2UK Topical Scar Treatment Market by Scar Type
      • 7.2.4.2.3UK Topical Scar Treatment Market by Product
    • 7.2.4.3France Topical Scar Treatment Market
      • 7.2.4.3.1France Topical Scar Treatment Market by End-use
      • 7.2.4.3.2France Topical Scar Treatment Market by Scar Type
      • 7.2.4.3.3France Topical Scar Treatment Market by Product
    • 7.2.4.4Russia Topical Scar Treatment Market
      • 7.2.4.4.1Russia Topical Scar Treatment Market by End-use
      • 7.2.4.4.2Russia Topical Scar Treatment Market by Scar Type
      • 7.2.4.4.3Russia Topical Scar Treatment Market by Product
    • 7.2.4.5Spain Topical Scar Treatment Market
      • 7.2.4.5.1Spain Topical Scar Treatment Market by End-use
      • 7.2.4.5.2Spain Topical Scar Treatment Market by Scar Type
      • 7.2.4.5.3Spain Topical Scar Treatment Market by Product
    • 7.2.4.6Italy Topical Scar Treatment Market
      • 7.2.4.6.1Italy Topical Scar Treatment Market by End-use
      • 7.2.4.6.2Italy Topical Scar Treatment Market by Scar Type
      • 7.2.4.6.3Italy Topical Scar Treatment Market by Product
    • 7.2.4.7Rest of Europe Topical Scar Treatment Market
      • 7.2.4.7.1Rest of Europe Topical Scar Treatment Market by End-use
      • 7.2.4.7.2Rest of Europe Topical Scar Treatment Market by Scar Type
      • 7.2.4.7.3Rest of Europe Topical Scar Treatment Market by Product
• 7.3Asia Pacific Topical Scar Treatment Market
  • 7.3.1Asia Pacific Topical Scar Treatment Market by End-use
    • 7.3.1.1Asia Pacific Hospitals Market by Country
    • 7.3.1.2Asia Pacific Clinics Market by Country
    • 7.3.1.3Asia Pacific Homecare Market by Country
  • 7.3.2Asia Pacific Topical Scar Treatment Market by Scar Type
    • 7.3.2.1Asia Pacific Atrophic Scars Market by Country
    • 7.3.2.2Asia Pacific Hypertrophic & Keloid Scars Market by Country
    • 7.3.2.3Asia Pacific Contracture Scars Market by Country
    • 7.3.2.4Asia Pacific Stretch Marks Market by Country
  • 7.3.3Asia Pacific Topical Scar Treatment Market by Product
    • 7.3.3.1Asia Pacific Creams Market by Country
    • 7.3.3.2Asia Pacific Gels Market by Country
    • 7.3.3.3Asia Pacific Silicon Sheets Market by Country
    • 7.3.3.4Asia Pacific Others Market by Country
  • 7.3.4Asia Pacific Topical Scar Treatment Market by Country
    • 7.3.4.1China Topical Scar Treatment Market
      • 7.3.4.1.1China Topical Scar Treatment Market by End-use
      • 7.3.4.1.2China Topical Scar Treatment Market by Scar Type
      • 7.3.4.1.3China Topical Scar Treatment Market by Product
    • 7.3.4.2Japan Topical Scar Treatment Market
      • 7.3.4.2.1Japan Topical Scar Treatment Market by End-use
      • 7.3.4.2.2Japan Topical Scar Treatment Market by Scar Type
      • 7.3.4.2.3Japan Topical Scar Treatment Market by Product
    • 7.3.4.3India Topical Scar Treatment Market
      • 7.3.4.3.1India Topical Scar Treatment Market by End-use
      • 7.3.4.3.2India Topical Scar Treatment Market by Scar Type
      • 7.3.4.3.3India Topical Scar Treatment Market by Product
    • 7.3.4.4South Korea Topical Scar Treatment Market
      • 7.3.4.4.1South Korea Topical Scar Treatment Market by End-use
      • 7.3.4.4.2South Korea Topical Scar Treatment Market by Scar Type
      • 7.3.4.4.3South Korea Topical Scar Treatment Market by Product
    • 7.3.4.5Singapore Topical Scar Treatment Market
      • 7.3.4.5.1Singapore Topical Scar Treatment Market by End-use
      • 7.3.4.5.2Singapore Topical Scar Treatment Market by Scar Type
      • 7.3.4.5.3Singapore Topical Scar Treatment Market by Product
    • 7.3.4.6Malaysia Topical Scar Treatment Market
      • 7.3.4.6.1Malaysia Topical Scar Treatment Market by End-use
      • 7.3.4.6.2Malaysia Topical Scar Treatment Market by Scar Type
      • 7.3.4.6.3Malaysia Topical Scar Treatment Market by Product
    • 7.3.4.7Rest of Asia Pacific Topical Scar Treatment Market
      • 7.3.4.7.1Rest of Asia Pacific Topical Scar Treatment Market by End-use
      • 7.3.4.7.2Rest of Asia Pacific Topical Scar Treatment Market by Scar Type
      • 7.3.4.7.3Rest of Asia Pacific Topical Scar Treatment Market by Product
• 7.4LAMEA Topical Scar Treatment Market
  • 7.4.1LAMEA Topical Scar Treatment Market by End-use
    • 7.4.1.1LAMEA Hospitals Market by Country
    • 7.4.1.2LAMEA Clinics Market by Country
    • 7.4.1.3LAMEA Homecare Market by Country
  • 7.4.2LAMEA Topical Scar Treatment Market by Scar Type
    • 7.4.2.1LAMEA Atrophic Scars Market by Country
    • 7.4.2.2LAMEA Hypertrophic & Keloid Scars Market by Country
    • 7.4.2.3LAMEA Contracture Scars Market by Country
    • 7.4.2.4LAMEA Stretch Marks Market by Country
  • 7.4.3LAMEA Topical Scar Treatment Market by Product
    • 7.4.3.1LAMEA Creams Market by Country
    • 7.4.3.2LAMEA Gels Market by Country
    • 7.4.3.3LAMEA Silicon Sheets Market by Country
    • 7.4.3.4LAMEA Others Market by Country
  • 7.4.4LAMEA Topical Scar Treatment Market by Country
    • 7.4.4.1Brazil Topical Scar Treatment Market
      • 7.4.4.1.1Brazil Topical Scar Treatment Market by End-use
      • 7.4.4.1.2Brazil Topical Scar Treatment Market by Scar Type
      • 7.4.4.1.3Brazil Topical Scar Treatment Market by Product
    • 7.4.4.2Argentina Topical Scar Treatment Market
      • 7.4.4.2.1Argentina Topical Scar Treatment Market by End-use
      • 7.4.4.2.2Argentina Topical Scar Treatment Market by Scar Type
      • 7.4.4.2.3Argentina Topical Scar Treatment Market by Product
    • 7.4.4.3UAE Topical Scar Treatment Market
      • 7.4.4.3.1UAE Topical Scar Treatment Market by End-use
      • 7.4.4.3.2UAE Topical Scar Treatment Market by Scar Type
      • 7.4.4.3.3UAE Topical Scar Treatment Market by Product
    • 7.4.4.4Saudi Arabia Topical Scar Treatment Market
      • 7.4.4.4.1Saudi Arabia Topical Scar Treatment Market by End-use
      • 7.4.4.4.2Saudi Arabia Topical Scar Treatment Market by Scar Type
      • 7.4.4.4.3Saudi Arabia Topical Scar Treatment Market by Product
    • 7.4.4.5South Africa Topical Scar Treatment Market
      • 7.4.4.5.1South Africa Topical Scar Treatment Market by End-use
      • 7.4.4.5.2South Africa Topical Scar Treatment Market by Scar Type
      • 7.4.4.5.3South Africa Topical Scar Treatment Market by Product
    • 7.4.4.6Nigeria Topical Scar Treatment Market
      • 7.4.4.6.1Nigeria Topical Scar Treatment Market by End-use
      • 7.4.4.6.2Nigeria Topical Scar Treatment Market by Scar Type
      • 7.4.4.6.3Nigeria Topical Scar Treatment Market by Product
    • 7.4.4.7Rest of LAMEA Topical Scar Treatment Market
      • 7.4.4.7.1Rest of LAMEA Topical Scar Treatment Market by End-use
      • 7.4.4.7.2Rest of LAMEA Topical Scar Treatment Market by Scar Type
      • 7.4.4.7.3Rest of LAMEA Topical Scar Treatment Market by Product

Chapter 8.Company Profiles

• 8.1Smith & Nephew PLC
  • 8.1.1Company Overview
  • 8.1.2Financial Analysis
  • 8.1.3Regional and Segmental Analysis
  • 8.1.4Research & Development Expense
  • 8.1.5SWOT Analysis
• 8.2Lumenis Be Ltd.
  • 8.2.1Company Overview
  • 8.2.2Recent strategies and developments:
    • 8.2.2.1Partnerships, Collaborations, and Agreements:
    • 8.2.2.2Product Launches and Product Expansions:
  • 8.2.3SWOT Analysis
• 8.3Merz Pharma GmbH & Co. KGaA
  • 8.3.1Company Overview
  • 8.3.2Recent strategies and developments:
    • 8.3.2.1Partnerships, Collaborations, and Agreements:
  • 8.3.3SWOT Analysis
• 8.4Sonoma Pharmaceuticals, Inc.
  • 8.4.1Company Overview
  • 8.4.2Financial Analysis
  • 8.4.3Regional Analysis
  • 8.4.4Research & Development Expenses
  • 8.4.5Recent strategies and developments:
    • 8.4.5.1Product Launches and Product Expansions:
  • 8.4.6SWOT Analysis
• 8.5Molnlycke Health Care AB
  • 8.5.1Company Overview
  • 8.5.2SWOT Analysis
• 8.6Suneva Medical, Inc.
  • 8.6.1Company Overview
  • 8.6.2Recent strategies and developments:
    • 8.6.2.1Product Launches and Product Expansions:
  • 8.6.3SWOT Analysis
• 8.7Perrigo Company PLC
  • 8.7.1Company Overview
  • 8.7.2Financial Analysis
  • 8.7.3Segmental and Regional Analysis
  • 8.7.4Research & Development Expenses
  • 8.7.5SWOT Analysis
• 8.8Cynosure, LLC (Clayton, Dubilier & Rice, LLC)
  • 8.8.1Company Overview
  • 8.8.2Recent strategies and developments:
    • 8.8.2.1Partnerships, Collaborations, and Agreements:
    • 8.8.2.2Product Launches and Product Expansions:
  • 8.8.3SWOT Analysis
• 8.9Newmedical Technology Inc.
  • 8.9.1Company Overview
  • 8.9.2SWOT Analysis
• 8.10.Integra LifeSciences Holdings Corporation
  • 8.10.1Company Overview
  • 8.10.2Financial Analysis
  • 8.10.3Segmental and Regional Analysis
  • 8.10.4Research & Development Expenses
  • 8.10.5SWOT Analysis

Chapter 9.Winning Imperatives of Topical Scar Treatment Market